M&A Deal Summary

Ginkgo Bioworks Acquires Novogy

On December 16, 2020, Ginkgo Bioworks acquired chemicals company Novogy

Acquisition Highlights
  • This is Ginkgo Bioworks’ 1st transaction in the Chemicals sector.
  • This is Ginkgo Bioworks’ 2nd transaction in the United States.
  • This is Ginkgo Bioworks’ 2nd transaction in Massachusetts.

M&A Deal Summary
Date 2020-12-16
Target Novogy
Sector Chemicals
Buyer(s) Ginkgo Bioworks
Deal Type Add-on Acquisition

Target

Novogy

Cambridge, Massachusetts, United States
Novogy is a Microbial Engineering Platform that modifies oleaginous yeasts to enhance yield and generate molecules for environmentally-friendly products. Novogy has developed best-in-class lipid-producing yeast strains over the past decade, with a particular focus on Yarrowia lipolytica. Ginkgo will be able to use Novogy's assets to accelerate the development of a range of commodities and fine chemicals and materials. Novogy is based in Cambridge, Massachusetts.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ginkgo Bioworks

Boston, Massachusetts, United States
Category Company
Founded 2008
Sector Life Science
DESCRIPTION

Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks was established in 2008 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 2 of 14
Sector (Chemicals) 1 of 1
Type (Add-on Acquisition) 2 of 11
State (Massachusetts) 2 of 5
Country (United States) 2 of 11
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-20 Gen9

Cambridge, Massachusetts, United States

Gen9, Inc. is a synthetic biology company founded by MIT, Harvard, and Stanford PhDs aimed at building the world’s first Moore’s law powered fabrication for biology to enable markets in biofuels, chemicals, and pharmaceuticals.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-17 Dutch DNA

Utrecht, Netherlands

Dutch DNA is a proprietary platform technology company focused on the development of fungal strains and fermentation processes for the production of proteins and organic acids. Dutch DNA was founded in 2015 and is based in Utrecht, Netherlands.

Buy -
Mergr

Product

Company

Legal